Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer

Abstract

Pre-CRT neoantigen-specific CD8+ T cell priming may be a key event in CRT responses where immune checkpoint molecules could be useful targets to enhance tumour regression.